Direct Answer
R&D intensity (R&D expense ÷ revenue) and SG&A intensity (SG&A expense ÷ revenue) measure how much of each revenue dollar a company reinvests in future products versus spends on overhead. Neither ratio has a universal "good" level - R&D intensity should be judged against industry peers and eventual payoff in growth or margin, while a declining SG&A intensity trend as a company scales is usually a genuinely positive signal of operating leverage.
Key Takeaways
- R&D intensity (R&D expense ÷ revenue) varies enormously by industry - high for pharma and software, near-zero for retailers and commodity producers - because it reflects a strategic choice about future competitiveness.
- Higher R&D intensity is not automatically better: it needs to eventually convert into revenue growth or margin expansion, or it is simply cash burn.
- SG&A intensity (SG&A expense ÷ revenue) reflects overhead and go-to-market cost structure; a declining trend as revenue scales is often genuine operating leverage.
- US GAAP requires R&D to be expensed immediately rather than capitalized like most physical capital investment, which can depress near-term earnings at R&D-heavy companies even while they build real long-term value.
- This accounting treatment distorts simple earnings-multiple comparisons between R&D-heavy and R&D-light companies - a real limitation to keep in mind, not just a footnote.
- Both ratios are most useful compared against a company's own history and close industry peers, not against unrelated sectors.
What Is R&D Intensity?
R&D intensity = R&D expense ÷ Revenue. It measures how much of each revenue dollar a company plows back into research and development of future products, drugs, or technology, rather than into current operations.
R&D intensity varies enormously by industry and business model, and that variation is structural, not a quality signal by itself. Pharmaceutical and biotechnology companies routinely spend 15-25% or more of revenue on R&D because new drug approvals are the entire basis of future revenue. Software companies often run high R&D intensity too, since the product itself is continuously re-engineered. Retailers, utilities, and commodity producers frequently show R&D intensity near zero, because their competitive advantage comes from distribution, scale, regulated infrastructure, or physical assets rather than new product development.
A high R&D intensity reflects a genuine strategic choice to prioritize future competitiveness over near-term profitability. But it is not automatically a positive signal. R&D spending only creates value if it eventually shows up as revenue growth, margin expansion, or a durable product advantage - R&D that never converts into any of those outcomes is simply cash burn with an optimistic label. The question worth asking is not "how much did the company spend on R&D" but "what did prior R&D spending actually produce."
What Is SG&A Intensity?
SG&A intensity = SG&A expense ÷ Revenue. SG&A (selling, general, and administrative expense) covers overhead: sales and marketing, executive compensation, back-office functions, legal, and corporate administration - the costs of running and selling the business that sit apart from the direct cost of producing the product.
SG&A intensity is a window into a company's cost structure and go-to-market efficiency. A declining SG&A intensity trend as a company grows revenue is often a genuinely positive signal, because it reflects operating leverage: a meaningful share of SG&A is fixed (a finance department, a sales leadership team, core corporate infrastructure) and doesn't need to grow proportionally with revenue. As revenue scales past that fixed base, SG&A intensity naturally falls, and each incremental revenue dollar drops more of itself to operating profit.
The reverse is a caution sign, not an automatic red flag: rising SG&A intensity can mean a company is over-investing in overhead ahead of revenue, or it can mean a deliberate, temporary investment phase (a new sales force, a geographic expansion) that management expects to pay off later. The trend needs context, not a snapshot.
| Ratio | Formula | What a favorable trend usually looks like |
|---|---|---|
| R&D intensity | R&D expense ÷ Revenue | Stable or rising intensity paired with revenue growth or margin expansion in later periods - not intensity alone. |
| SG&A intensity | SG&A expense ÷ Revenue | A gradually declining ratio as revenue scales past a largely fixed overhead base (operating leverage). |
Why Does GAAP Treatment of R&D Distort Comparisons?
Under US GAAP, R&D costs are almost always expensed immediately as incurred, not capitalized as an asset and depreciated over time. This is a deliberate accounting choice - the future economic benefit of research is considered too uncertain to reliably capitalize, unlike a factory, a piece of equipment, or (in narrow, specific circumstances) certain software development costs.
This creates a real distortion worth flagging explicitly when comparing companies. A company that invests heavily in physical capital spreads that cost over the asset's useful life through depreciation, so it hits earnings gradually. A company that invests just as heavily in R&D takes the entire hit to earnings in the period the spending happens. Two companies investing the same dollar amount in their future can show very different near-term accounting earnings purely because of what kind of investment it is - not because one company is performing better than the other.
The practical consequence: comparing an R&D-heavy company (say, a biotech or enterprise software firm) to an R&D-light company (say, an industrial manufacturer) on a simple trailing P/E or earnings multiple can be misleading, because the R&D-heavy company's reported earnings are depressed by expensing investment that a capital-intensive peer gets to spread across years. This doesn't mean R&D-heavy companies are automatically undervalued - it means the earnings multiple alone isn't a fair comparison without adjusting for, or at least acknowledging, this accounting difference.
Worked Hypothetical Example
A hypothetical software company reports $500 million of revenue, $90 million of R&D expense, and $175 million of SG&A expense for the year.
- R&D intensity = $90 million ÷ $500 million = 18.0%
- SG&A intensity = $175 million ÷ $500 million = 35.0%
The prior year, the same hypothetical company reported $400 million of revenue, $76 million of R&D expense, and $156 million of SG&A expense.
- R&D intensity = $76 million ÷ $400 million = 19.0%
- SG&A intensity = $156 million ÷ $400 million = 39.0%
Reading the trend: R&D intensity held roughly steady (19.0% to 18.0%), meaning R&D spending grew roughly in line with revenue - a reasonable pattern for a company sustaining its product investment. SG&A intensity fell from 39.0% to 35.0% even as SG&A dollars grew from $156 million to $175 million, because revenue grew faster (25% year over year) than SG&A dollars (12%). That combination - SG&A dollars growing slower than revenue - is the operating-leverage signal: fixed overhead is being spread across a larger revenue base.
- This example is hypothetical - taxes, other operating expenses, and one-time items are simplified.
- A single year-over-year comparison cannot establish a durable trend; multiple years are needed to confirm operating leverage is real rather than a one-period anomaly.
- Actual results can differ materially, and this example is not a projection for any real company.
Common Mistakes and How to Avoid Them
| Mistake | Why it causes problems | Better practice |
|---|---|---|
| Comparing R&D intensity across unrelated industries | A biotech's 20% R&D intensity and a grocery chain's 0% intensity reflect different business models, not different management quality. | Compare R&D intensity against close industry peers and the company's own multi-year history. |
| Treating high R&D intensity as automatically bullish | Spending alone doesn't create value - R&D that never converts into revenue growth or margin expansion is just an expense. | Track whether prior R&D spending eventually shows up in revenue growth, new product launches, or margin trends. |
| Ignoring the GAAP expensing distortion in earnings multiples | An R&D-heavy company can look expensive on a simple P/E purely because its investment is expensed immediately rather than capitalized like physical capital. | Adjust for or at least acknowledge the accounting treatment before comparing R&D-heavy and R&D-light companies on earnings multiples alone. |
| Reading one quarter of SG&A intensity as a trend | A single period can be skewed by a one-time marketing push, restructuring charge, or seasonal spending pattern. | Look at SG&A intensity over several years alongside revenue growth to confirm a genuine operating-leverage trend. |
Risks and Limitations
R&D and SG&A intensity are backward-looking accounting ratios. Neither one directly measures whether past spending was well allocated - a company can maintain high R&D intensity for years while producing few commercially successful products, and a company can show falling SG&A intensity while under-investing in sales capacity it will later need to rebuild.
Reported R&D and SG&A figures are also not perfectly standardized across companies. Some companies classify certain engineering or product costs as cost of revenue rather than R&D; others bundle marketing into SG&A while some break it out separately. Always check the financial statement footnotes for how a specific company defines these line items before comparing it to peers.
Neither ratio should be used in isolation. Combine R&D and SG&A intensity with revenue growth, gross margin trends, and return-on-capital measures such as the DuPont breakdown to see whether spending choices are actually translating into business results.
Frequently Asked Questions
Is higher R&D intensity always better?
No. Higher R&D intensity only reflects a strategic choice to spend more of revenue on future products - it becomes "better" only if that spending eventually converts into revenue growth, margin expansion, or a durable competitive advantage. R&D spending that never shows up in later results is simply cash burn, regardless of how it compares to peers.
Why does R&D intensity vary so much between industries?
R&D intensity reflects how central research is to a company's competitive model. Pharmaceutical and software companies routinely spend a large share of revenue on R&D because new products are the core of what they sell. Retailers and commodity producers spend little or none, because their advantage comes from distribution, scale, or physical assets rather than new product development.
What does a declining SG&A intensity trend usually mean?
A falling SG&A-to-revenue ratio as a company grows often signals operating leverage - fixed corporate overhead (management salaries, back-office systems, marketing infrastructure) gets spread across a larger revenue base, so each additional dollar of sales costs less in overhead. It is a genuinely positive signal when it results from scale rather than from cutting spending that the business actually needs.
Why is R&D expensed instead of capitalized under GAAP?
US GAAP requires most R&D costs to be expensed as incurred rather than capitalized as an asset and depreciated over time, because the future benefit of research is considered too uncertain to reliably capitalize. This is different from how physical capital investments like a factory or equipment are treated, and it means R&D-heavy companies can show depressed near-term accounting earnings even while building real long-term value.
Does the GAAP treatment of R&D distort earnings comparisons?
Yes, in a specific and important way. Because R&D is expensed immediately while physical capital investment is capitalized and depreciated, a simple earnings multiple can make an R&D-heavy company look expensive relative to an R&D-light company, even when the R&D-heavy company is investing just as much in its future - the expense just hits the income statement immediately instead of being spread out.
Should R&D and SG&A intensity be compared across industries?
Not directly. Because R&D and SG&A intensity are shaped by business model and industry structure, the most meaningful comparison is against a company's own history and against close industry peers with a similar model - not against companies in unrelated sectors, where a large gap in either ratio usually reflects a different kind of business rather than better or worse management.
Related Reading
- Fundamental Analysis: How to Analyze a Stock Step by Step - the full pillar guide this page is part of.
- Business Efficiency Ratios - the hub covering asset turnover, per-employee productivity, and DuPont efficiency alongside R&D and SG&A intensity.
- DuPont Efficiency Breakdown - how the net margin that R&D and SG&A intensity directly affect feeds into ROE through the DuPont decomposition.
- Profit Margins Explained - how gross, operating, and net margins are calculated and where R&D and SG&A sit in the income statement.